ClinicalTrials.Veeva

Menu

Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer (PROSTRACK)

C

Centre Georges Francois Leclerc

Status

Terminated

Conditions

Prostate Cancer

Treatments

Radiation: IGRT Associated With IMRT
Other: CBCT
Other: fiducial marker (kV imaging)

Study type

Interventional

Funder types

Other

Identifiers

NCT02279693
2014-A00122-45

Details and patient eligibility

About

This study evaluates the dose received by the prostate with in vivo dosimetry when delivering image guided radiation therapy (IGRT) associated with intensity modulated radiation therapy (IMRT) for patients with localized prostate cancer using two repositioning techniques: fiduciary markers or soft tissues.

Full description

10 participants will receive a cone beam computed tomography (CBCT) repositioning, while the other 10 will receive a kV imaging of fiducial marker repositioning. The principal objective is to evaluate and compare the dose received by the prostate using two repositioning techniques.

Enrollment

3 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • male > 18 years
  • carcinoma of the prostate histologically confirmed
  • OMS 0-1
  • localized stage
  • favorable, intermediate and unfavorable groups according to NCCN or D'Amico classification
  • patients must have signed a written informed consent form
  • patients must be affiliated to a Social Health Insurance.

Exclusion criteria

  • metastasis
  • indication for pelvic radiation
  • anticoagulant therapy
  • lateral or bilateral hip replacement
  • patient receiving an adult protective services
  • Patient unable to comply with the required medical follow-up for geographic, social or psychological reasons

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3 participants in 2 patient groups

CBCT
Other group
Description:
cone beam computed tomography (CBCT) repositioning
Treatment:
Radiation: IGRT Associated With IMRT
Other: CBCT
fiducial markers
Other group
Description:
kV imaging of fiducial marker repositioning
Treatment:
Other: fiducial marker (kV imaging)
Radiation: IGRT Associated With IMRT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems